Endonovo Therapeutics (ENDVD) Stock Price, News & Analysis

Company Overview

Endonovo Therapeutics, Inc. is a biotechnology and medical-device company focused on regenerative medicine and bioelectronic therapies. The company has developed technologies intended to use electrical or electromagnetic stimulation to support tissue repair, reduce inflammation, and assist with recovery from injury or disease.

Its product portfolio has included SofPulse, a noninvasive pulsed electromagnetic field therapy device designed for applications such as pain management, wound care, and the reduction of swelling. Endonovo has also pursued additional regenerative-medicine platforms and therapeutic applications based on bioelectronic stimulation.

Publicly available information about Endonovo Therapeutics’ current operations, geographic reach, and leadership is limited. The company’s activities and product offerings may have changed over time, and the available information does not support a more detailed description without risking inaccuracies.

Key Stats

• Today's Range: N/A
• 50-Day Range: N/A
• 52-Week Range: N/A
• Volume: N/A
• Average Volume: 11,850 shs
• Market Capitalization: $1.52 million
• P/E Ratio: N/A
• Dividend Yield: N/A
• Price Target: N/A
• Consensus Rating: N/A

Industry, Sector and Symbol

• Stock Exchange: OTCMKTS
• Sector: Healthcare
• Industry: Pharmaceuticals
• Sub-Industry: Pharmaceuticals
• Current Symbol: OTCMKTS:ENDVD
• CIK: N/A
• Web: endonovo.com
• Phone: (800) 489-4774
• Fax: N/A
• Employees: 147,000
• Year Founded: 2011

Profitability

• EPS (Trailing Twelve Months): ($10.00)
• Trailing P/E Ratio: N/A
• Forward P/E Ratio: N/A
• P/E Growth: N/A
• Net Income: -$400 thousand
• Net Margins: -6,075.54%
• Pretax Margin: N/A
• Return on Equity: N/A
• Return on Assets: -279.35%

Debt

• Debt-to-Equity Ratio: N/A
• Current Ratio: N/A
• Quick Ratio: N/A

Sales & Book Value

• Annual Sales: $170 thousand
• Price / Sales: 0.00
• Cash Flow: N/A
• Price / Cash Flow: N/A
• Book Value: ($0.59) per share
• Price / Book: N/A

Miscellaneous

• Outstanding Shares: 1,227,000
• Free Float: N/A
• Market Cap: $1.52 million
• Optionable: Not Optionable
• Beta: 1.98